Harleen Kaur

Harleen Kaur is a Senior Clinical Trial Manager at CymaBay Therapeutics since January 2022, with prior experience as a Clinical Trial Manager at Prothena Corporation plc from September 2019 to November 2021 and in Clinical Operations at Gilead Sciences between January 2016 and September 2019. Harleen has demonstrated expertise in managing clinical trial processes, overseeing protocol deviation reconciliations, conducting TMF audits, and training Clinical Research Associates. At B&K Medical Research Center, where Harleen served as Clinical Research Coordinator/Project Manager from June 2012 to November 2015, responsibilities included supervising global studies and managing recruitment and processing of regulatory documents. Harleen holds a Bachelor of Science in Biology from the University of California, Davis, and multiple Master of Science degrees in Health Informatics from National University.